| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8821358 | Clinical Imaging | 2018 | 18 Pages |
Abstract
Lung adenocarcinomas with HER2 gene mutation exhibit an aggressive behavior manifesting by higher incidence of local invasion, compared to KRAS and EGFR mutant controls, and a nodal metastatic spread compared to KRAS-mutant control. This is the first radiogenomics study of HER2 mutations in lung cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Peter Sawan, Andrew J. Plodkowski, Angela E. Li, Bob T. Li, Alexander Drilon, Marinela Capanu, Michelle S. Ginsberg,